OE MRI to Predict Treatment Response After TACE in HCC Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
OE MRI to Predict Treatment Response After TACE in HCC Patients	Digestive System Diseases, Digestive System Neoplasms, Hypoxia, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Enrolling by invitation	Not applicable	2026-06-01		NCT07617038

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Centre de Recherche du Centre Hospitalier de l'Université de Montréal	9
Laboratory ISTCT UMR6030 CNRS of Caen (France)	1
Université de Montréal	43

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
CRCHUM	Montreal	Canada	1